These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8118369)

  • 1. [The clinically occult breast cancer. Screening and preoperative marking].
    Kubista E; Adler A; Seifert M; Wolf G
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():82-4. PubMed ID: 8118369
    [No Abstract]   [Full Text] [Related]  

  • 2. Opportunistic breast cancer early detection in Tyrol, Austria 1996-2004. Is a mammography-screening program necessary?
    Frede TE
    Eur J Radiol; 2005 Jul; 55(1):130-8. PubMed ID: 15925467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Breast screening in Geneva?].
    Schaefer P
    Helv Chir Acta; 1992 May; 59(1):195-202. PubMed ID: 1526828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of breast cancer in Austria 1983-1987].
    Gerstner GJ; Tuchmann A; Friedl HP
    Gynakol Rundsch; 1989; 29 Suppl 2():236-40. PubMed ID: 2613022
    [No Abstract]   [Full Text] [Related]  

  • 5. No major impact of mammography screening on the age specific incidence rates of breast cancer in the Netherlands.
    Verkooijen HM; Fioretta G; van der Heiden M; Koot VC; Bouchardy C
    Int J Cancer; 2006 Dec; 119(12):2988; author reply 2989-90. PubMed ID: 17016822
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic mode and tumor staging of breast cancers in the setting of opportunistic screenings].
    Graf O; Obermayer M; Scheurecker A; Hopf G; Kramer J; Frühwald F
    Rofo; 2006 Feb; 178(2):221-6. PubMed ID: 16435254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Advanced Breast Cancer Stages at Subsequent Participation in Mammography Screening.
    Weigel S; Heindel W; Heidrich J; Heidinger O; Hense HW
    Rofo; 2016 Jan; 188(1):33-7. PubMed ID: 26485700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
    Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
    Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of self-reported screening mammography and impact on breast cancer mortality in Austria.
    Vutuc C; Haidinger G; Waldhoer T
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):485-90. PubMed ID: 9746962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of screening mammography and change in surgeons' attitudes on the pattern of primary care of breast cancer at a community hospital.
    Goldsweig HG; O'Sullivan M
    J Surg Oncol; 1990 Sep; 45(1):10-3. PubMed ID: 2381210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer.
    Duijm LE; Groenewoud JH; Roumen RM; de Koning HJ; Plaisier ML; Fracheboud J
    Breast Cancer Res Treat; 2007 Nov; 106(1):113-9. PubMed ID: 17219049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the results of 137 subclinical breast lesions excisions. Value of ultrasonography in the early diagnosis of breast cancer].
    Jacob D; Brombart JC; Muller C; Lefèbvre C; Massa F; Depoerck A
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):27-31. PubMed ID: 9091540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
    Anderson WF; Jatoi I; Devesa SS
    Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and harms of detecting clinically occult breast cancer.
    Amir E; Bedard PL; Ocaña A; Seruga B
    J Natl Cancer Inst; 2012 Oct; 104(20):1542-7. PubMed ID: 22988040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
    Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
    Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trial of early detection of breast cancer by mass screening in Miyagi Prefecture].
    Abe R; Sato T; Yoshida K; Hariu T; Takahashi K; Kanno H; Matoba N
    Nihon Geka Gakkai Zasshi; 1985 Aug; 86(8):941-7. PubMed ID: 4058414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creating awareness about the painless nature of early breast cancer lump is important in low-income countries.
    Garg P; Bansal M; Garg M; Arora B
    Breast J; 2010; 16(1):101-2. PubMed ID: 19825004
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
    Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
    Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.